References
- Laasonen E G, Troupp H. Volume growth rate of acoustic neuromas. Neuroradiology 1986; 28: 203–7
- Ogawa K, Kanzaki J, Ogawa S, et al. The growth rate of acoustic neuromas. Acta Otolaryngol (Stockh) 1991; 157–63, Suppl 487
- Nedzelski J M, Schessel D A, Pfleiderer A, et al. Conservative management of acoustic neuromas. Otolaryngol Clin North Am 1992; 25: 691–705
- Noren G, Greitz D. The natural history of acoustic neurinomas. Proceedings of the first international conference on acoustic neuroma., M Tos, J Thomsen. Kugler, Amsterdam 1992; 191–2
- Charabi S, Thomsen J, Mantoni M, et al. Acoustic neuroma/vestibular schwannoma, growth, surgical and non surgical consequences of the wait and see policy. Otolaryngol Head Neck Surg 1995; 113: 5–14
- Wennerberg J, Mercke U. Growth potential of acoustic neuromas. Am J Otol 1989; 10: 293–96
- Rasmussen N, Tribukait B, Thomsen J, et al. Implications of DNA characterization of human acoustic neuromas. Acta Otolaryngol (Stockh) 1984; 278–81, Suppl 406
- Wiet R J, Ruby S G, Bauer GP. Proliferating cell nuclear antigen in the determination of growth rates in acoustic neuromas. Am J Otol 1994; 3: 294–8
- Welkoborsky H-J, Haibt G, Mann W J, et al. Comparison of cytomorphometric characteristics to histology and proliferation markers in acoustic neuromas. Ann Otol Rhinol Laryngol 1994; 103: 49–53
- Charabi S, Engel P, Charabi B, et al. Growth of vestibular schwannoma in vitro model employing monoclonal antibody Ki-67 and DNA flow cytometry. Am J Otol 1996; 17: 301–6
- Lee J K, Kim T S, Chiocca E A, et al. Growth of human schwannomas in the subrenal capsule of the nude mouse. Neurosurgery 1990; 4: 598–605
- Charabi S, Rygaard J, Klinken L, et al. Subcutaneous growth of human acoustic schwannomas in athymic nude mice. Acta Otolaryngol (Stockh) 1994; 114: 399–405
- Charabi S, Simonsen K, Charabi B, et al. Nerve growth factor receptor expression in heterotransplanted vestibular schwannoma in athymic nude mice. Acta Otolaryngol (Stockh) 1996; 116: 59–63
- Biersack H J, Grunwald F, Kropp J. Single photon emission computed tomography imaging of brain tumors. Semin Nucl Med 1991; 21: 2–10
- Tonami N. Diagnosis of tumor with Thallium-201. Kaku Igaku 1993; 30: 449–55
- Kahn D, Follet K A, Bushnell D L, et al. Diagnosis of recurrent brain tumor: value of 201T1 SPECT vs 18F-Flurodeoxyglucose PET. AJR 1994; 163: 1459–65
- Nakagawara J, Fukuoka S, Takahashi S, et al. Assessment of vascularity and permeability in brain tumor using SPECT and 99mTc-DTPA-human serum albumin in relation to 201T1 SPECT. Kaku Igaku 1994; 31: 117–24
- Borbely K, Fulham M J, Brooks R A, et al. PET-Fluo-rodeoxyglucose of cranial and spinal neuromas. J Nucl Med 1992; 33: 1931–4
- Kume N, Suga K, Kazuya N, et al. Relation between thallium-201 uptake and tumour proliferative ability in thyreoid nodules. Eur J Nucl Med 1996; 23: 376–82